HOME >> MEDICINE >> NEWS
Less invasive surgery effective in treatment of reflux disease

CHICAGO Laparoscopic (minimally invasive) surgery to treat severe reflux disease was effective in relieving symptoms and was associated with high rates of patient satisfaction five years after the procedure, according to a study in the October issue of Archives of Surgery, one of the JAMA/Archives journals.

Laparoscopic anti-reflux surgery has been gaining in popularity for the treatment of severe symptomatic gastroesophageal reflux disease (GERD), according to background information in the article. Few previous studies have reported five-year follow-up for a large group of patients who have undergone laparoscopic surgery to treat severe reflux disease.

Patrick Pessaux, M.D., of the University Hospital, Angers, France, and colleagues evaluated patients who had undergone one of three types of laparoscopic anti-reflux surgery in one of 31 hospital centers between January 1992 and December 1998. Outcome data covering five or more years was available for 1,340 patients, 815 men and 525 women (average age 49.3 years). The average follow-up was 7.1 years. Patients were evaluated post-operatively using a standardized questionnaire including questions on gastrointestinal symptoms and satisfaction with surgery.

"In this study, the intraoperative and postoperative complication rates were 2.1 percent and 2.6 percent, respectively, with a subsequent operation rate of 4.4 percent at five years," the researchers report. "Of interest, overall patient satisfaction following surgery was high, with 93.1 percent of patients satisfied with their long-term outcome and 94.1 percent willing to have the surgery again. Although nearly 10 percent of patients resumed taking antisecretory medication, in most no evidence of reflux recurrence could be found."

"In conclusion, the results of this study do not differ significantly from the data reported in the literature, suggesting that laparoscopic antireflux surgery is an effective long-term procedure, is well
'"/>

Contact: Jean-Pierre Arnaud, M.D.
jparnaud@chu-angers.fr
JAMA and Archives Journals
17-Oct-2005


Page: 1 2

Related medicine news :

1. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
2. USC-led study suggests exercise reduces risk of developing invasive breast cancer
3. New data supports a non-invasive approach to routine prenatal genetic testing
4. New research explores limits of non-invasive coronary imaging tests
5. A simple, noninvasive test measures survival time in adult pulmonary hypertension
6. German researchers develop first non-invasive test to measure skin aging
7. Gamma Knife offers non-invasive treatment for vascular disorders, tumors in the brain
8. ESC recommends interdisciplinary collaboration in non-invasive imaging
9. Minimally invasive procedure restores blood flow to kidneys, research suggests
10. A non-invasive method for measuring beta cell mass during diabetes
11. A simple protocol avoids unnecessary invasive procedures

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Less invasive surgery effective treatment reflux disease

(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... disease Amyotrophic lateral sclerosis (ALS), also known as Lou ... can be classified into four distinct stages, report pathologists ... of Pennsylvania in the Annals of Neurology . ... tissues shows, for the first time, how the fatal ... the central nervous system to other regions of brain ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... Imprivata ®, a leading global provider ... Imprivata OneSign ® leads the single sign-on (SSO) category ... & Services report . CIOs and other healthcare executives ... performance of its products and the quality of its ... is integral to their long-term healthcare IT strategy. ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  ... company focused on the development and commercialization of novel ... announced the pricing of an underwritten public offering of ... offering price of $33.01 per share.  In addition, Intercept ... up to an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: